Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness 365 Provider Education Read More Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More Oct 7 2020 | HFSA Submits Comments in Response to CY 2021 Medicare Physician Fee Schedule Proposed Rule HFSA News Advocacy Read More Oct 7 2020 | HFSA Responds to Medicare Proposal to Eliminate “Inpatient Only” List HFSA News Advocacy Read More Pagination First page « First Previous page ‹ Previous … Page 61 Page 62 Page 63 Page 64 Current page 65 Page 66 Page 67 Page 68 Page 69 … Next page Next › Last page Last »
Oct 27 2020 | New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status Industry News Industry Read More
Oct 20 2020 | New HFSA Resources on Disparities in Heart Failure Now Available HFSA News Heart Failure Awareness 365 Provider Education Read More
Oct 13 2020 | Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Industry News Industry Read More
Oct 7 2020 | HFSA Submits Comments in Response to CY 2021 Medicare Physician Fee Schedule Proposed Rule HFSA News Advocacy Read More
Oct 7 2020 | HFSA Responds to Medicare Proposal to Eliminate “Inpatient Only” List HFSA News Advocacy Read More
